Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.
about
Diacylglycerol Kinase-ε: Properties and Biological RolesHaemolytic uraemic syndrome.Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advancesComplement related kidney diseases: Recurrence after transplantation.New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.The expanding phenotypic spectra of kidney diseases: insights from genetic studies.The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase ε.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomicsFactors influencing treatment of atypical hemolytic uremic syndrome.Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations.Towards precision nephrology: the opportunities and challenges of genomic medicine.Thrombotic Microangiopathy and the Kidney.Thrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease
P2860
Q28072499-52C3FA1C-2D2F-4C8E-9708-CB5242D29A36Q30244707-8A192CE2-1E85-4494-AA25-B1475557F3E5Q33421800-1047D9C0-C407-41D4-8819-BF46A0760B49Q33421861-8E89ACE7-1938-4397-97BD-7E359EC69A4FQ33425911-3F0C3116-47B5-461D-83AF-1420E697AEDCQ36306802-7370F50A-05E4-4E37-9347-B160F1B79FA7Q37522557-AC2A10E3-FAB3-4E06-A9F4-B8F1F3500344Q38304445-D1DE1EB2-E980-41FD-A876-3ABF3F60FC1CQ38885083-C8FBDC6B-8FAF-4696-A21E-480746723E99Q40193437-083F62E9-7676-44BD-9512-4A72D3979F7FQ42086661-C3F4725A-FF2A-44CC-8976-599E94100B4BQ42368363-1248C392-1801-4FDD-8995-3FFFA35E8B39Q42858176-A20F4563-19F5-4AC8-9495-DB1291E3F2CAQ47937936-F2B68A13-7C52-433A-86B9-7A84164D3D50Q48171722-2901A840-BE61-49A9-ADD2-B1C2D087109FQ50085453-1C824F6C-FE85-49A8-A2D3-8E1725B77D4EQ58754943-E3B0AA0C-AAA6-4528-8A16-88CE885A73D6
P2860
Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@ast
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@en
type
label
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@ast
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@en
prefLabel
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@ast
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@en
P2093
P2860
P50
P356
P1476
Complement mutations in diacyl ...... cal hemolytic uremic syndrome.
@en
P2093
Antonia Peña
Bernd Hoppe
Laura Lopez
Maria Luisa Justa Roldan
Marta Adragna
Pilar Sánchez-Corral
Sheila Pinto
P2860
P304
P356
10.2215/CJN.01640214
P577
2014-08-18T00:00:00Z